Clinical Trials Directory

Trials / Completed

CompletedNCT00180817

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages.

Status
Completed
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This study is being done to see if there are any long term health related issues in women with APA and recurrent miscarriages.

Detailed description

The association between APA and thrombosis is well documented. Both LA and ACA are often detected in individuals with SLE but there is no prospective data on the risk of thrombosis in women who present with recurrent miscarriages in association with APA. This study should significantly advance medical knowledge of the natural history of primary antiphospholipid syndrome (PAPS) which is essential to enable optimal management of relatively young women who may be at risk of complications, some of which are potentially life threatening.

Conditions

Timeline

Start date
1998-09-01
Primary completion
2005-08-31
Completion
2005-08-31
First posted
2005-09-16
Last updated
2022-08-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00180817. Inclusion in this directory is not an endorsement.

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies. (NCT00180817) · Clinical Trials Directory